You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 32 No. 11, November 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Erythrocyte Soluble Catechol-O-Methyl Transferase Activity in Primary Affective Disorder

A Clinical and Genetic Study

Elliot S. Gershon, MD; Wulff Z. Jonas

Arch Gen Psychiatry. 1975;32(11):1351-1356.


Abstract

• Erythrocyte catechol-O-methyl transferase (COMT) activity was studied in 53 patients with primary affective disorders and 38 controls and in selected relatives. Patients with affective disorders tended to have higher activity levels than normals, after correcting for sex differences. The COMT activity was positively correlated between relatives and is heritable. Within families, elevation of COMT activity distinguished healthy relatives from probands and ill relatives. This suggests that COMT activity elevation and affective illness do not show independent assortment and implies that COMT activity identifies genetic vulnerability to affective disorder.



Author Affiliations

From the Department of Research, Jerusalem Mental Health Center, Ezrath Nashim, Israel (Mr Jonas); and the Section on Psychogenetics, Adult Psychiatry Branch, National Institute of Mental Health, Bethesda, Md (Dr Gershon). Mr Jonas is now with the Council for Research and Development, Prime Minister's Office, Jerusalem.


Footnotes

Accepted for publication May 24, 1975.

Reprint requests to the Unit on Clinical Psychogenetics, Adult Psychiatry Branch, National Institute of Mental Health, Rm 3N218, Bldg 10, 9000 Rockville Pike, Bethesda, MD 20014 (Dr Gershon).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

PhRMA White Paper on ADME Pharmacogenomics
Williams et al.
J Clin Pharmacol 2008;48:849-889.
ABSTRACT | FULL TEXT  

Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
Gogos et al.
Proc. Natl. Acad. Sci. USA 1998;95:9991-9996.
ABSTRACT | FULL TEXT  

Plasma Amine Oxidase and Genetic Vulnerability to Schizophrenia
Baron et al.
Arch Gen Psychiatry 1983;40:275-279.
ABSTRACT  

Activities of Types A and B MAO and Catechol-O-methyltransferase in Blood Cells and Skin Fibroblasts of Normal and Chronic Schizophrenic Subjects
Groshong et al.
Arch Gen Psychiatry 1978;35:1198-1205.
ABSTRACT  

Genetic Strategies in Biological Psychiatry
Rieder and Gershon
Arch Gen Psychiatry 1978;35:866-873.
ABSTRACT  

Plasma MAO Activity Unrelated to Genetic Vulnerability to Primary Affective Illness
Gershon et al.
Arch Gen Psychiatry 1977;34:731-734.
ABSTRACT  

CNS Monoamine Metabolism in Bipolar Affective Disorder: Evaluation Using a Peripheral Decarboxylase Inhibitor
Garfinkel et al.
Arch Gen Psychiatry 1977;34:735-739.
ABSTRACT  

Reduced MAO Activity in First-Degree Relatives of Individuals With Bipolar Affective Disorders: A Preliminary Report
Leckman et al.
Arch Gen Psychiatry 1977;34:601-606.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.